Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Phosphorus magnetic resonance spectroscopy

Fukuzako H (2001). Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. World Journal of Biological Psychiatry,... [Pg.265]

R. Reddy and M. S. Keshavan, Phosphorus magnetic resonance spectroscopy its utility in examining the membrane hypothesis of schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids, 2003,69,401-405. [Pg.151]

J. A. Stanley, P. C. Williamson, D. J. Drost, T. J. Carr, R. J. Rylett, A. Malla and R. T. Thompson, An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch. Gen. Psychiatry, 1995, 52,399-406. [Pg.151]

G. Calabrese, R. F. Deicken, G. Fein, E. L. Merrin, F. Schoenfeld and M. W. Weiner, 31-Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biol. Psychiatry, 1992,32, 26-32. [Pg.152]

M. Rango, C. Bonifati and N. Bresolin, Parkinson s disease and brain mitochondrial dysfunction a functional phosphorus magnetic resonance spectroscopy study. /. Cereb. Blood Flow Metab., 2006, 26,283-290. [Pg.153]

A. Lorek, Y. Takei, E. B. Cady, J. S. Wyatt, J. Penrice, A. D. Edwards, D. Peebles, M. Wylezinska, H. Owen-Reece V. Kirkbride, et al.. Delayed (secondary) cerebral energy failure after acute hypoxia-ischemia in the newborn piglet continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr. Res., 1994, 36, 699-706. [Pg.153]

E. B. Cady, O. Iwata, A. Bainbridge, J. S. Wyatt and N. J. Robertson, Phosphorus magnetic resonance spectroscopy 2 h after perinatal cerebral hypoxia-ischemia prognosticates outcome in the newborn piglet. /. Neurochem., 2008,107,1027-1035. [Pg.153]

Theberge J, Al-Semaan Y, Jensen JE, Williamson PC, Neufeld RW, et al. 2004. Comparative study of proton and phosphorus magnetic resonance spectroscopy in schizophrenia at 4 tesla. Psychiatry Res 132 33-39. [Pg.441]

Son, T.-D., Roux, M., Ellenberger, M. E. (1975). Interaction of Mg Mons with nucleoside triphosphates by phosphorus magnetic resonance spectroscopy, Nucl. Acid. Res., 2 ... [Pg.572]

Nanny, M. A. and Minear, R. A. (1997). Characterization of soluble unreactive phosphorus using P nuclear magnetic resonance spectroscopy. Mar. [Pg.375]

Pettegrew, J. W., Keshavan, M. S., Panchalingam, K. et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch. Gen. Psychiat. 48 563-568,1991. [Pg.958]

Moore, C. M., Christensen, J. D., Lafer, B. et al. Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects a phosphorus-31 magnetic resonance spectroscopy study. Am. J. Psychiat. 154 116-118,1997. [Pg.958]

Turner BL, Richardson AE. Identification of scyllo-inositol phosphates in soil by solution phosphorus-31 nuclear magnetic resonance spectroscopy. Soil Sci. Soc. Am. J. 2004 68 802-808. [Pg.319]

M. Rudin and A. Sauter, In vivo phosphorus-31 NMR potential and limitations. in In-Vivo Magnetic Resonance Spectroscopy III In-Vivo MR Spectroscopy Potential and Limitations, M. Rudin (ed.), Springer-Verlag, Berlin, 1992,161-188. [Pg.146]

T. Kato, S. Takahashi, T. Shioiri and T. Inubushi, Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. /. Affect. Disord., 1992, 26,223-230. [Pg.150]

T. Kato, T. Shioiri, J. Murashita, H. Hamakawa, T. Inubushi and S. Takahashi, Later-alized abnormality of high-energy phosphate and bilateral reduction of phosphomo-noester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia. Psychiatry Res., 1995, 61,151-160. [Pg.151]

Joqueviel, C., Martini, R., Gilard, V., Malet-Martino, M., Canal, P., and Niemeyer, U., Urinary excretion of cyclophosphamide in humans, determined by phosphorus-31 nuclear magnetic resonance spectroscopy, Drug Metab. Disposition, 26, 418-428, 1998. [Pg.234]

Hinsberger AD, Williamson PC, Carr TJ, Stanley JA, Drost DJ, et al. 1997. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia. J Psychiatry Neurosci 22 111-117. [Pg.436]

See other pages where Phosphorus magnetic resonance spectroscopy is mentioned: [Pg.158]    [Pg.405]    [Pg.425]    [Pg.3714]    [Pg.18]    [Pg.356]    [Pg.468]    [Pg.64]    [Pg.158]    [Pg.405]    [Pg.425]    [Pg.3714]    [Pg.18]    [Pg.356]    [Pg.468]    [Pg.64]    [Pg.951]    [Pg.952]    [Pg.115]    [Pg.514]    [Pg.13]    [Pg.147]    [Pg.158]    [Pg.15]    [Pg.146]    [Pg.146]    [Pg.147]    [Pg.406]   
See also in sourсe #XX -- [ Pg.356 ]



SEARCH



Phosphorus magnetic resonance

© 2024 chempedia.info